Florida Gov. Ron DeSantis signed the Prescription Drug Reform Act on May 3 to limit pharmacy benefit manager practices and hold "Big Pharma accountable."
The law bans clawbacks, mail-order rebates, spread pricing, patient steering and networks solely composed of affiliate pharmacies, according to a news release. It also aims to block data-sharing without patients' consent.
On the "Big Pharma" side, the legislation requires drugmakers to report price increases surpassing 15 percent after one year and cumulative list price increasing 30 percent or more within three years.
At the federal level, about half a dozen bills looking to regulate the PBM industry are wading through committees.